Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q04656: Variant p.Ala1362Val

Copper-transporting ATPase 1
Gene: ATP7A
Feedback?
Variant information Variant position: help 1362 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Alanine (A) to Valine (V) at position 1362 (A1362V, p.Ala1362Val). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from small size and hydrophobic (A) to medium size and hydrophobic (V) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In MNK; decreased protein abundance; increased protein degradation; does not affect interaction with ATOX1; does not affect interaction with COMMD1; subcellular location restricted to TGN; does not localizes to the plasma membrane in response to elevated copper levels; impaired copper transport activity. Any additional useful information about the variant.


Sequence information Variant position: help 1362 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 1500 The length of the canonical sequence.
Location on the sequence: help VASIDLSRKTVKRIRINFVF A LIYNLVGIPIAAGVFMPIGL The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         VASIDLSRKTVKRIRINFVFALIYNLVGIPIAAGVFMPIGL

Mouse                         VASIDLSRKTVKRIRINFVFALIYNLVGIPIAAGVFLPIGL

Rat                           VASIDLSRKTVKRIRINFVFALIYNLIGIPIAAGVFLPIGL

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 1500 Copper-transporting ATPase 1
Transmembrane 1357 – 1374 Helical
Alternative sequence 82 – 1499 Missing. In isoform 6.



Literature citations
Defective copper-induced trafficking and localization of the Menkes protein in patients with mild and copper-treated classical Menkes disease.
Ambrosini L.; Mercer J.F.B.;
Hum. Mol. Genet. 8:1547-1555(1999)
Cited for: VARIANT MNK VAL-1362; Characterization of ATP7A missense mutants suggests a correlation between intracellular trafficking and severity of Menkes disease.
Skjoerringe T.; Amstrup Pedersen P.; Salling Thorborg S.; Nissen P.; Gourdon P.; Birk Moeller L.;
Sci. Rep. 7:757-757(2017)
Cited for: FUNCTION; CATALYTIC ACTIVITY; SUBCELLULAR LOCATION; CHARACTERIZATION OF VARIANTS MNK VAL-628; ARG-633; TYR-653; ARG-666; ARG-727; ASP-728; PRO-761; ASN-802; HIS-844; VAL-860; ARG-876; GLU-876; ARG-1000; ARG-1005; VAL-1007; ASP-1015; ASN-1037; GLY-1044; ARG-1255; GLU-1282; GLU-1300; GLY-1301; GLU-1302; VAL-1302; LYS-1304; ALA-1305; GLY-1305; ASP-1308; ARG-1315; VAL-1325; VAL-1362; ARG-1369; PRO-1373; THR-1393 AND PHE-1397; CHARACTERIZATION OF VARIANT OHS ARG-924;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.